By Ben James ( July 1, 2010, 7:01 PM EDT) -- An ex-PDL BioPharma Inc. executive will have to testify in a patent suit MedImmune LLC brought against PDL over MedImmune's respiratory drugs Synagis and the yet-to-be released motavizumab, having failed to convince a judge that coming to the U.S. to be deposed would be unduly burdensome for him....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.